HGF and prostate carcinoma: In search of endogenous inhibitors of TMPRSS2, Ko and coworkers performed co-immunoprecipitation assays on prostate cancer cells and identified HGF activator inhibitor (HAI)-1 and HAI-2 as interaction partners of TMPRSS2 (Table 1) [135].